Enhanced bimatoprost ophthalmic solution

Details for Australian Patent Application No. 2006227757 (hide)

Owner Allergan, Inc.

Inventors Chang-Lin, Joan-En; Chang, Chin-Ming; Jordan, R. Scott; Schiffman, Rhett M.; Chang, James N.

Agent Davies Collison Cave

Pub. Number AU-B-2006227757

PCT Pub. Number WO2006/101839

Priority 11/083,261 16.03.05 US

Filing date 14 March 2006

Wipo publication date 28 September 2006

Acceptance publication date 14 July 2011

International Classifications

A61K 31/5575 (2006.01)

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 47/18 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives

A61P 27/06 (2006.01) Drugs for disorders of the senses

Event Publications

11 October 2007 PCT application entered the National Phase

  PCT publication WO2006/101839 Priority application(s): WO2006/101839

14 July 2011 Application Accepted

  Published as AU-B-2006227757

10 November 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006227766-Wire guides having novel outer surface areas and reservoirs for enhancing hydrophilic properties and delivering therapeutic agents

2006227755-Flanged interbody fusion device